AU Patent

AU2020277546B2 — Crystal form of pyrimidine sulfonamide compound and preparation method therefor

Assigned to Wuxi Biocity Biopharmaceutics Co Ltd · Expires 2025-07-03 · 1y expired

What this patent protects

Disclosed are a crystal form (I) of a pyrimidine sulfonamide compound and a preparation method therefor. The present invention relates to an application thereof in the preparation of a medicament for treating diseases related to ETA receptor antagonists.

USPTO Abstract

Disclosed are a crystal form (I) of a pyrimidine sulfonamide compound and a preparation method therefor. The present invention relates to an application thereof in the preparation of a medicament for treating diseases related to ETA receptor antagonists.

Drugs covered by this patent

Patent Metadata

Patent number
AU2020277546B2
Jurisdiction
AU
Classification
—
Expires
2025-07-03
Drug substance claim
No
Drug product claim
No
Assignee
Wuxi Biocity Biopharmaceutics Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.